Bispectral Index Value Changes During Induction and Surgical Decompression in Head Injury Patients

March 21, 2018 updated by: Dhritiman Chakrabarti, National Institute of Mental Health and Neuro Sciences, India

This study was conducted in two parts:

  1. This first part was designed to determine thiopentone dose requirement for induction of anaesthesia with and without the use of Bispectral Index monitoring - Participant and Care Provider in appropriate study arm blinded.
  2. As a secondary outcome, Bispectral index monitoring was used to observe changes in neuronal function in intraoperative period as well as haemodynamic changes intraoperatively - Participant and Care Provider blinded.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Surgery for traumatic brain injury is an anaesthetic challenge fraught with complications such as brain bulge, excessive bleeding, hypotension etc. As yet there are no anaesthetic regimen guidelines to follow for induction of anaesthesia in neurotrauma surgeries. Although the functional effect of anaesthetic agents on neuronal tissue is known quite well, there is lack of studies documenting the effect of these anaesthetic agents on head injured patients. It is also not known whether the requirement of anaesthetic agent in the same as a non head injured patient. This study was designed to assess the requirement of anaesthetic thiopentone in head injured patients and compare the anaesthetic usage with and without Bispectral index (BIS) monitoring. We also observed the real time change in neuronal function using Bispectral Index monitoring after craniotomy, i.e. effectively decompression and release of intracranial pressure intraoperatively.

Study Type

Interventional

Enrollment (Actual)

60

Phase

  • Phase 4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Head injury patients coming for surgery

Exclusion Criteria:

  • Hypotension/Arrythmias at time of induction
  • Extra Dural Hemorrhage
  • Extracranial injuries
  • Scalp lacerations
  • History of Seizures
  • No consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Group BIS
Thiopentone dosing during induction of anaesthesia based on guidance of Bispectral Index values.
Thiopentone was administered in 50 mg boluses during induction of anaesthesia, until reduction of Bispectral Index value to less than 50, and total dose of thiopentone recorded.
NO_INTERVENTION: Group Clinical
Thiopentone dosing during induction of anaesthesia based on clinical guidance targeted to loss of eyelash reflex or loss of response to noxious stimulus.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Thiopentone requirement
Time Frame: Beginning of anaesthetic induction till End of anaesthetic induction
Difference of thiopentone requirement with and without use of Bispectral Index guidance during induction of anaesthesia in traumatic brain injury patients.
Beginning of anaesthetic induction till End of anaesthetic induction

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Intraoperative Bispectral Index changes
Time Frame: Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
Observation of Bispectral Index changes during craniotomy and decompression.
Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
Intraoperative Systolic blood pressure changes
Time Frame: Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
Observation of Systolic blood pressure changes during craniotomy and decompression.
Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
Intraoperative Mean blood pressure changes
Time Frame: Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
Observation of Mean blood pressure changes during craniotomy and decompression.
Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
Intraoperative heart rate changes
Time Frame: Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.
Observation of heart rate changes during craniotomy and decompression.
Beginning of anaesthetic Induction till patient is shifted to post-anaesthesia care unit.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Muthuchellappan Radhakrishnan, MD, DM, National Institute of Mental Health and Neuro Sciences, India

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2016

Primary Completion (ACTUAL)

May 30, 2017

Study Completion (ACTUAL)

June 15, 2017

Study Registration Dates

First Submitted

March 21, 2018

First Submitted That Met QC Criteria

March 21, 2018

First Posted (ACTUAL)

March 29, 2018

Study Record Updates

Last Update Posted (ACTUAL)

March 29, 2018

Last Update Submitted That Met QC Criteria

March 21, 2018

Last Verified

March 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Traumatic Brain Injury

Clinical Trials on Bispectral Index

3
Subscribe